Sara Feola

Person

Latest publications

  1. E-pub ahead of print

    Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

    Fontana, F., Fusciello, M., Groeneveldt, C., Capasso, C., Chiaro, J., Feola, S., Liu, Z., Mäkilä, E., Salonen, J., Hirvonen, J., Cerullo, V. & Santos, H. A., 17 May 2019, In : ACS Nano. 14 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

    Ylösmäki, E., Malorzo, C., Capasso, C., Honkasalo, O., Fusciello, M., Martins, B., Ylösmäki, L., Louna, A., Feola, S., Paavilainen, H., Peltonen, K., Hukkanen, V., Viitala, T. & Cerullo, V., 5 Sep 2018, In : Molecular therapy. 26, 9, p. 2315-2325 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Accepted/In press

    Development of Biohybrid Multistage Nanovaccines for Melanoma

    Fontana, F., Capasso, C., Shahbazi, M-A., Liu, D., Fusciello, M., Feola, S., Zhang, H., Mäkilä, E., Salonen, J., Hirvonen, J. T., Cerullo, V. & Almeida Santos, H., 2018, (Accepted/In press).

    Research output: Conference materialsAbstractResearchpeer-review

View all (6) »

ID: 100399183